Bildkälla: Stockfoto

BioInvent: Green Light for Phase IIa with BI-1206 - Redeye

Redeye is encouraged by the positive End-of-Phase I meeting with the FDA and provides a brief comment.

Redeye is encouraged by the positive End-of-Phase I meeting with the FDA and provides a brief comment.
Börsvärldens nyhetsbrev
ANNONSER